Not Yet Recruiting
Orlistat Overcoming Third-generation EGFR-TKI Resistance
NCT06818955
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +9 more
- Locations
-
Not specified
Clinical trial condition
Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.
NCT06818955
Not specified
NCT06789796
Not specified
NCT06786312
NCT06786208
NCT06784206
NCT06779539
Not specified
NCT06780839
NCT06725537
Not specified
NCT06760676
Not specified
NCT06757114
Not specified